WO2017061616A1 - Bioabsorbable staple - Google Patents

Bioabsorbable staple Download PDF

Info

Publication number
WO2017061616A1
WO2017061616A1 PCT/JP2016/080002 JP2016080002W WO2017061616A1 WO 2017061616 A1 WO2017061616 A1 WO 2017061616A1 JP 2016080002 W JP2016080002 W JP 2016080002W WO 2017061616 A1 WO2017061616 A1 WO 2017061616A1
Authority
WO
WIPO (PCT)
Prior art keywords
staple
erection
photograph
bioabsorbable
metal material
Prior art date
Application number
PCT/JP2016/080002
Other languages
French (fr)
Japanese (ja)
Inventor
広夫 内田
顕成 檜
花田 幸太郎
Original Assignee
国立大学法人名古屋大学
国立研究開発法人産業技術総合研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 国立大学法人名古屋大学, 国立研究開発法人産業技術総合研究所 filed Critical 国立大学法人名古屋大学
Priority to JP2017544249A priority Critical patent/JP6823321B2/en
Publication of WO2017061616A1 publication Critical patent/WO2017061616A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/08Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters

Definitions

  • the present invention relates to a bioabsorbable staple, and more particularly, to a staple that has a shape that does not have a bending point so that it is less likely to break due to corrosion when placed in a living body, and a suturing effect can be obtained over a long period of time. .
  • sutures In surgical operations, thread has been used as a means for suturing wounds. However, in recent years, sutures can be sutured more quickly and easily. Further, postoperative suture failure is almost the same as that of hand stitching.
  • staples are used. Staples are used in various surgical sites such as skin, blood vessels, intestinal tract, bones, muscles, and organs. In addition, it is used by a method depending on the suture location, such as puncturing and stitching from outside the body into the skin, or indwelling in the living body after suturing a blood vessel, intestinal tract, organ or the like in the living body.
  • staples that are indwelled in a living body include metals such as stainless steel, titanium, tantalum, and the like, and amorphous diamond-like carbon films formed on the surfaces of the metals, which are insoluble in the human body.
  • metals such as stainless steel, titanium, tantalum, and the like
  • amorphous diamond-like carbon films formed on the surfaces of the metals which are insoluble in the human body.
  • Patent Document 2 a staple made of a metal material soluble in the human body in order to close a wound on the skin, fascia or internal organ is also known (see Patent Document 2).
  • both insoluble and soluble in vivo are known as staples to be placed in the living body.
  • staples placed in the living body are desirably made of a material that is soluble in the living body.
  • most of the staples placed in the living body are made of an insoluble material such as titanium, and there is a problem that staples made of a soluble material are hardly used.
  • the present invention has been made in order to solve the above-mentioned problems.
  • the connecting part for connecting the parts By forming the connecting part for connecting the parts into a shape including a curved part that does not have a bending point, the force for suturing the living tissue is dispersed and the force does not concentrate at a specific location, so the staple breaks (3)
  • the staple breaks By forming at least a part of the erection part so as to be positioned on the distal end side of the insertion part with respect to the line connecting the top part and the top part of the connection part, two stitches are formed. It was newly found that the sutured part can be brought into close contact by being pressed down by the installation part in addition to the entrance part.
  • an object of the present invention is to provide a bioabsorbable staple that is difficult to break when placed in a living body.
  • the present invention relates to the following bioabsorbable staples.
  • a staple formed of a biodegradable metal material The staple includes two insertion portions to be inserted into a living tissue, an erection portion that straddles a suture site, and a connection portion that connects the insertion portion and the erection portion,
  • the connecting portion is formed in a shape including a curved portion having no bending point, and
  • a bioabsorbable staple in which at least a part of the erection part is located on a distal end side of the insertion part from a line connecting the top part and the top part of the connection part.
  • the connecting portion of the bioabsorbable staple is formed in a shape including a curved portion having no bending point, it is difficult to break even if it is placed in the living body. Therefore, the stitched portion can be adhered over a long period of time.
  • the connecting portion of the staple is formed in a shape including a curved portion that does not have a bending point, at least a part of the erection portion is arranged on the distal end side of the insertion portion with respect to a line connecting the top portion and the top portion of the connecting portion. It can form so that it may be located in.
  • the stitched portion can be brought into close contact with the installation portion in addition to the two insertion portions, so that the close-contact efficiency of the stitched portion can be increased.
  • FIG. 1 is a diagram illustrating at least one example of an embodiment of a staple 1.
  • FIG. 2 is a diagram for explaining the “bending point”.
  • FIGS. 3A to 3D are diagrams showing examples of shapes including a curved portion having no bending point.
  • 4A to 4C are diagrams showing another example of the staple 1 embodiment.
  • 5A and 5B are views showing shapes that are not included in the embodiment of the staple 1.
  • 6A and 6B are diagrams for explaining the boundary between the erection part 3 and the connecting part 4, and
  • FIG. 6C is a diagram illustrating another example of the erection part 3.
  • FIG. 7 is a view showing still another example of the embodiment of the staple 1.
  • FIG. 8 is a drawing-substituting photograph, FIG. 8A is Example 1, FIG.
  • FIG. 8B is Example 2
  • FIG. 8C is Example 3
  • FIG. 8D is Example 4
  • FIG. 8 (E) is a photograph of Example 5 after bending by 180 ° while pressing a wire against a stainless steel rod having a different diameter (curvature radius).
  • FIG. 9 is a drawing-substituting photograph
  • FIG. 9A is a photograph of the staple produced in Example 6
  • FIG. 9B is a photograph of the staple produced in Comparative Example 1
  • FIG. 9C is a puncture in the intestinal tract.
  • FIG. 9D is a photograph of the staple of Comparative Example 1 punctured in the intestinal tract.
  • FIG. 10 is a drawing-substituting photograph
  • FIG. 10 is a drawing-substituting photograph
  • FIG. 10 is a drawing-substituting photograph
  • FIG. 10 is a drawing-substituting photograph
  • FIG. 10 is a drawing-substituting photograph
  • FIG. 10 is a drawing-sub
  • FIG. 10 (A) is a photograph of a HE-stained section of a week after the operation of Example 7 (magnified 20 times), and FIG. 10 (B) is a week of the operation of Example 7 after one week. It is the photograph (200 time expansion) of the section
  • FIG. 10 (C) is a photograph of a HE-stained section 1 week after surgery in Comparative Example 2 (20-fold enlargement), and FIG. 10D is a photograph of a HE-stained section 1 week after surgery in Comparative Example 2 (200). Double magnification).
  • FIG. 11 is a drawing-substituting photograph, FIG.
  • FIG. 11 (A) is a photograph of a HE-stained section 2 times after the operation of Example 7 (magnification 40 times), and FIG. 11 (B) is 2 weeks after the operation of Example 7. It is the photograph (100 time expansion) of the section
  • FIG. 11 (C) is a photograph of a HE-stained section of Comparative Example 2 two weeks after surgery (magnification 40 times), and FIG. 11D is a photograph of a HE-stained section of Comparative Example 2 two weeks after surgery (100). Double magnification).
  • FIG. 12 is a drawing-substituting photograph
  • FIG. 12 (A) is a photograph of a HE-stained section of 4 weeks after the operation of Example 7 (100 times magnification), and FIG.
  • FIG. 12 (B) is 4 weeks after the operation of Example 7. It is the photograph (400 times expansion) of the section
  • stained HE. 12C is a photograph of a HE-stained section of Comparative Example 2 4 weeks after surgery (100 times magnification), and FIG. 12D is a photograph of a HE-stained section of Comparative Example 2 4 weeks after surgery (400). Double magnification).
  • FIG. 1 is a diagram illustrating an example of a staple embodiment.
  • a staple 1 shown in FIG. 1 connects two insertion portions 2 to be inserted into a living tissue where suture is necessary by a surgical operation or the like, an erection portion 3 straddling the suture location, and the insertion portion 2 and the erection portion 3.
  • Two connecting portions 4 are included.
  • the connecting part 4 is formed in a shape including a curved part having no bending point.
  • "bending point” means the bending center location 5 when a wire is bent around a specific location, and a smooth situation without the bending center location 5 continues. Different from the curved part.
  • the “bending point” since the “bending point” is not included, the force for bringing the sutured portion into close contact is less likely to be concentrated on the specific portion of the staple, and as a result, it is difficult to break even if it is corroded in vivo.
  • the “shape including a bending portion that does not have a bending point” in the present application refers to all shapes that do not include a bending point and can connect the insertion portion 2 and the erection portion 3 by including the bending portion.
  • the whole connecting portion 4 is smoothly and continuously curved in the same direction, and as shown in FIG. 3 (B), part or all of the connecting portion 4 is curved. Includes a wavy portion, and the connecting portion 4 is curved in the same direction as a whole, and as shown in FIG. 3C, the connecting portion 4 includes a straight portion and a curved portion.
  • 3A to 3C are gradually curved from the insertion portion 2 toward the inside of the staple 1, but as shown in FIG. 3D, the connection portion 4 is gradually curved. It is also possible to first bend from the insertion portion 2 toward the outside of the staple 1 and then gradually bend toward the inside of the staple 1.
  • the connection portion 4 having the shape shown in FIG. 3D is also partially or entirely wavy as shown in FIG. 3B, as shown in FIG. It may include a straight line portion.
  • FIG. 3 is an illustration of a specific shape of the staple 1 of the present application, and is not limited to the example shown in FIG. As long as it is “a shape including a curved portion having no bending point”, a shape not shown may be used.
  • the staple 1 according to the embodiment is put into a stapler cartridge, and the staple 1 is pushed out to puncture a living tissue.
  • the staple 1 having the shape shown in FIG. 3D can also be used, when the connecting portion 4 protrudes outside the staple 1, the insertion portion 2 is separated from the wall surface of the cartridge. Therefore, from the viewpoint of stability at the time of puncturing, as shown in FIGS. 3A to 3C, the connecting portion 4 is gradually curved from the insertion portion 2 toward the inside of the staple 1. Is preferred.
  • At least a part of the erection part 3 is located on the distal end 21 side of the insertion part 2 from the line (dotted line in FIG. 1) connecting the top part 41 of the one connection part 4 and the top part 41 of the other connection part 4. ing.
  • a "top part” means the location which has the distance H most from the line
  • FIG. 1 shows an example in which all of the erection part 3 is located on the distal end 21 side of the insertion part 2 with respect to the line connecting the top part 41 and the top part 41, but the position of the erection part 3 and the top part 41 described above. There are no restrictions as long as the relationship is satisfied.
  • FIG. 4 shows another example of the embodiment of the staple 1
  • FIG. 4 (A) shows that the construction part 3 is formed in a wave shape, and one of the waves is opposite to the tip 21 from the line connecting the top parts 41. 4B, the erection part 3 is formed in a wave shape, and all of the waves protrude toward the tip 21 side from the line connecting the top parts 41, and FIG.
  • An example is shown in which a plurality of waves protrude from the line connecting the top portions 41 to the side opposite to the tip 21. What is necessary is just to determine the shape of the construction part 3 suitably according to the shape of the location to sew.
  • FIG. 5 shows an example not included in the embodiment of the staple 1.
  • a substantially U-shaped staple shown in FIG. 5A and a substantially U-shaped staple shown in FIG. 5B are known.
  • any part of the erection part 3 is closer to the distal end 21 side of the insertion part 2 than the line connecting the top part 41 and the top part 41 of the connecting part 4. It is not included in the staple 1 embodiment because it is not located.
  • FIG. 6 is a diagram for explaining the boundary between the erection part 3 and the connection part 4.
  • the center point R of the virtual circle having an arc at two arbitrary points of the connecting portion 4 is a staple. 1 inside. Even when the connecting portion 4 includes a straight portion, R does not become outside the staple 1.
  • the center point R of the virtual circle having an arc of any two points is the part that is outside the staple 1. is there.
  • FIG. 7 shows still another example of the embodiment of the staple 1.
  • the insertion portion 2 of the staple 1 is substantially linear in order to make it easier to puncture a living tissue. Therefore, when the connecting portion 4 comes into contact with the living tissue after puncturing the insertion portion 2, the staple 1 is gradually bent from a substantially straight line, so that it is difficult to puncture the living tissue. Therefore, as shown in FIG. 7, at least a part of the erection part 3 is connected to the insertion part 2 and the connection part which are further on the tip 21 side of the insertion part 2 from the line connecting the top part 41 and the top part 41 of the connection part 4. 4 may be formed so as to be positioned closer to the distal end 21 side of the insertion portion 2 than the line 25 connecting the boundaries 24 of the four.
  • the erection part 3 is more likely to come into contact with the stitched portion, so that the adhesion efficiency of the stitched portion can be increased.
  • the boundary between the insertion part 2 and the connection part 4 may be a place where the insertion part 2 begins to bend.
  • the staple 1 shown in each embodiment is characterized by having no bending point.
  • the curvature radius of the curved portion is increased. It is preferable to do.
  • the “curvature radius” means a radius of an imaginary circle having an arc at two arbitrary points of the curved portion of the connecting portion 4.
  • the radius of curvature of the connecting portion 4 is preferably 0.1 mm or more, more preferably 0.275 mm or more, and still more preferably 0.4 mm or more.
  • the amplitude may be reduced so as to have the above-described curvature radius.
  • the amplitude may be reduced so as to have the above-described curvature radius.
  • what is necessary is just to make it become the same curvature radius as the above also when the construction part 3 is made into a waveform.
  • the staple 1 has, for example, a vertical width (distance from the distal end of the insertion portion 2 to the erection portion 3) of 2 to 5 mm (a vertical width after puncturing the living tissue is 0.5 mm to 3 mm), and a horizontal width (puncture
  • the distance between the insertion portion 2 and the insertion portion 2) can be exemplified by about 1 mm to 5 mm.
  • the size may be appropriately adjusted according to the suture location.
  • the staple 1 shown in each embodiment is not particularly limited as long as it is a metal material that biodegrades when placed in the living body.
  • the biodegradable metal material pure magnesium or a magnesium alloy, pure calcium or a calcium alloy, pure zinc or a zinc alloy, or the like is used.
  • Preferred is pure magnesium or a magnesium alloy.
  • magnesium alloy magnesium is a main component, H, C, N, O, Na, P, K, Ca, Fe, B, Al, Si, V, Cr, Mn, Zn. , Y, La, Ce, Nd, Sm, Gd, Tb, Dy, and Yb containing at least one element selected from rare earth elements.
  • the staple 1 shown in each embodiment may be made of only a biodegradable metal material, but the biodegradable metal material may be coated with a biodegradable resin.
  • a biodegradable resin By coating with a biodegradable resin, the progress of corrosion of the staple 1 when placed in the living body can be adjusted.
  • the biodegradable resin is not particularly limited as long as it is enzymatically or non-enzymatically decomposed in vivo and the decomposed product does not exhibit toxicity.
  • polylactic acid polyglycolic acid, polylactic acid-polyglycolic acid copolymer, polycaprolactone, polylactic acid-polycaprolactone copolymer, polyorthoester, polyphosphazene, polyphosphoric acid ester, polyhydroxybutyric acid, polymalic acid
  • poly Examples include ⁇ -amino acids, collagen, gelatin, laminin, heparan sulfate, fibronectin, vitronectin, chondroitin sulfate, hyaluronic acid, polyhydroxybutyrate valeric acid, polysalicylic acid, polypeptides, polysaccharides, chitin, and chitosan.
  • the biodegradable metal material or the biodegradable resin coated with the biodegradable metal material may carry a physiologically active substance.
  • the physiologically active substance is not particularly limited as long as it is supported on the surface of the biodegradable metal material or biodegradable resin.
  • the physiologically active substance may be dissolved in a solvent or the like and applied.
  • Physiologically active substance is not particularly limited as long as it is a known drug used for treatment or the like.
  • a staple placed in the body is a foreign substance for a living body, post-operative inflammation or the like can be suppressed by carrying an anti-inflammatory agent, an antibiotic, an antiallergic agent, or the like.
  • a hemostatic agent or the like may be carried if the suture site is a blood vessel, and an anticancer agent or the like may be carried if the suture site is cancer.
  • the manufacturing method of the staple 1 shown in each embodiment is not particularly limited as long as the connecting portion 4 is formed in a shape including a curved portion having no bending point.
  • a metal mold corresponding to at least the shapes of the connecting part 4 and the erection part 3 is produced, and a thin plate made of a biodegradable metal material may be press-molded.
  • die of the shape of the insertion part 2, the connection part 4, and the installation part 3 should be produced, and the melted biodegradable metal material should just be injection-molded.
  • a press or injection molding mold may be adjusted, or a staple produced by pressing or the like may be sheared or ground.
  • the staple 1 shown in each embodiment may be set in a known stapler cartridge for living tissue.
  • the staple 1 shown in each embodiment is connected when the connecting portion 4 is positioned on the distal end side of the insertion portion 2 with respect to the erection portion 3, so that the portion contacting the connecting portion 4 of the cartridge is linear. At least a part of the part is separated from the part. For this reason, if a conventional U-shaped portion that presses the staple of the stapler is used, the pressing force may concentrate on the top 41 of the connecting portion 4. Therefore, it is preferable that the pressing part of the stapler using the staple 1 shown in each embodiment has a shape that fits the connecting part 4 and the erection part 3.
  • the obtained alloy ingot was hot-extruded under conditions of a temperature of 400 ° C., an extrusion ratio of 15 and an extrusion speed of 60 mm / min, and processed into a rod having an outer diameter of 17 mm.
  • a billet (outer diameter 10 mm ⁇ length 25 mm) was cut out from this alloy bar, and hot extrusion was performed under the conditions of a temperature of 400 ° C. and an extrusion ratio of 28 to obtain an alloy wire having an outer diameter of 1.9 mm.
  • the alloy wire was inserted into a drawing die and drawn at room temperature.
  • the area reduction rate of the alloy wire cross section before and after the drawing process was adjusted to 30% or less, and after the drawing process, annealing was performed at 400 ° C. for 30 minutes. Then, drawing and annealing were repeated until the wire diameter of the alloy wire became 0.25 mm.
  • the obtained alloy wire having a wire diameter of 0.25 mm was cut to a length of 25 mm and bent 180 ° while being pressed against a stainless steel rod having the following diameter (curvature radius).
  • FIG. 8A is Example 1
  • FIG. 8B is Example 2
  • FIG. 8C is Example 3
  • FIG. 8D is Example 4
  • FIG. 8E is Example 5. It is a photograph after bending 180 degrees. Three samples were prepared and bent with the above-mentioned curvature radius. As shown in Table 1, when the sample of Example 1 (alloy wire) was bent by 180 °, cracks were observed in the bent portion (not broken), but the samples of Examples 2 to 5 No cracks were observed in the bent part.
  • an immersion experiment system simulating the inside of a living body was prepared, and the corrosion change when the samples of Examples 1 to 5 were immersed in the immersion experiment system was examined.
  • the samples of Examples 1 to 5 were immersed in a 0.5% nitric acid aqueous solution for 20 seconds, acid-washed, then subjected to ultrasonic washing for 1 minute each in the order of pure water and acetone, and dried.
  • 10 ml of bovine serum (New Zealand; Thermo Fisher Scientific Gibco) was placed in a test tube to prepare an immersion experiment system.
  • FIG. 9A is a photograph of the produced staple.
  • FIG. 9C is a photograph of staples punctured in the intestinal tract.
  • Example 6 the intestinal tract was punctured in the same manner as in Example 6 except that the stainless steel bar having a diameter of 0.5 mm was not pressed against the erection part 3 of the staple and the staple in the pressed state was changed to Comparative Example 1.
  • FIG. 9B is a photograph of the staple of Comparative Example 1
  • FIG. 9D is a photograph of the staple punctured in the intestinal tract.
  • Example 7 Instead of the raw material of Example 1, magnesium (Mg), rare earth (RE; misch metal containing Nd as a main component), and yttrium (Y) are 96% Mg-3.0% RE-1.0% by weight.
  • An alloy wire was prepared in the same procedure as in Example 1 except that Y was used, and then a wire with a wire diameter of 0.25 mm was pressed into 3 mm (left and right insertion portions 2 and connecting portions 4). (Distance connecting the boundary 24) ⁇ 2.5 mm (the length from the insertion portion 2 to the top portion 41 of the connecting portion 4).
  • the tip of the staple insertion portion 2 was tapered at an angle of 45 degrees toward the inside of the staple with respect to the insertion direction.
  • sutures were performed in the animal body according to the following procedure, and pathological findings were examined.
  • Three pigs were laparotomized under general anesthesia, and a small intestine machine suture was performed at 50 cm from the terminal ileum using a suture instrument (Ethicon (Johnson &Johnson); Powered ECHELON FLEX).
  • the abdomen was raised after 1 week, 2 weeks and 4 weeks, and the pathological findings around the sutured part were observed. The pathological findings were observed by visual observation around the sutured part and by HE staining.
  • HE staining was performed according to the following procedure.
  • A The polished specimen was washed with water after resin removal.
  • B Immersion in Weigert's iron hematoxylin solution for 60 minutes.
  • C After washing with water, it was immersed in an eosin solution for 7 minutes.
  • D Dehydrated with ethanol, sealed with xylene, and sealed.
  • FIG. 10 (A) is a photograph of a HE-stained section 1 week after surgery (20 times magnification)
  • FIG. 10B is a photograph of a HE-stained section 1 week after surgery (200 times magnification)
  • FIG. 11 (A). Is a photograph of a HE-stained section 2 weeks after surgery (40 times magnification)
  • FIG. 11B is a photograph of a HE-stained section 2 weeks after surgery (100 times magnification)
  • FIG. 12 (B) are photographs of a 4-week post-surgery HE-stained section (400 times magnification).
  • Example 2 Example except that titanium staple (Ethicon (Johnson &Johnson); ECR45W) was used instead of the staple of Example 7 and the small intestine machine was sutured at a position shifted from Example 7 (50 cm from the stomach pylorus). At the same time, small intestine suture was performed. The observation of the pathological findings was performed in the same procedure as in Example 7.
  • titanium staple Ethicon (Johnson &Johnson); ECR45W
  • FIG. 10 (C) is a photograph of a HE-stained section 1 week after surgery (20 times magnification)
  • FIG. 10D is a photograph of a HE-stained section 1 week after surgery (200 times magnification)
  • FIG. 11 (C). Is a photograph of a HE-stained section 2 weeks after surgery (40 times magnification)
  • FIG. 11 (D) is a photograph of a HE-stained section 2 weeks after surgery (100 times magnification)
  • FIG. 12 (C) is after surgery.
  • a photograph of a 4-week HE-stained section (100-fold magnification) and FIG. 12D are photographs of a 4-week post-surgery HE-stained section (400-fold magnification).
  • Example 7 Mg staple
  • Comparative Example 2 Ti staple
  • inflammatory cell infiltration was observed around the metal, but the effect was limited to a relatively narrow range.
  • B In both Mg staple and Ti staple, the inflammation around the metal spread from the mucosa to the serosal surface. The degree of inflammation was similar.
  • C In the Ti staple, inflammation spread by neutrophils, eosinophils, and lymphocytes, mainly metal, was stronger.
  • the stitched portion can be adhered for a long period of time. Therefore, it is useful for surgery in a medical institution.

Abstract

Provided is a bioabsorbable staple (1) that is less likely to break when kept inside a living body. The staple (1) is made of a biodegradable metal material. The staple (1) comprises: two insertion parts (2) to be inserted into biological tissue; a bridge part (3) that extends over a site to be sutured; and connection parts (4) connecting the respective insertion parts (2) and the bridge part (3). The connection part (4) is formed in a shape including a curved part having no bend point. At least a portion of the bridge part (3) is located on the tip-end side of the insertion parts (2) than a line connecting the respective top parts (41, 41) of the connection parts (4).

Description

生体吸収性ステープルBioabsorbable staple
 本発明は、生体吸収性ステープルに関し、特に、屈曲点を有さない形状とすることで、生体内に留置した際に、腐食による破断を起こり難くし、長期間にわたり縫合効果が得られるステープルに関する。 The present invention relates to a bioabsorbable staple, and more particularly, to a staple that has a shape that does not have a bending point so that it is less likely to break due to corrosion when placed in a living body, and a suturing effect can be obtained over a long period of time. .
 外科手術の際には、傷口を縫合する手段として糸が使用されてきたが、近年は、より早く且つ簡単に縫合することができ、更に、術後の縫合不全も手縫いと比較してほとんど変わらない手段として、ステープルが使用されている。ステープルは、皮膚、血管、腸管、骨や筋肉あるいは臓器等の様々な外科手術箇所で用いられている。また、体外から皮膚等に刺入れ縫合、或いは生体内で血管、腸管や臓器等を縫合した後に生体内に留置する等、縫合箇所に応じた方法で使用されている。 In surgical operations, thread has been used as a means for suturing wounds. However, in recent years, sutures can be sutured more quickly and easily. Further, postoperative suture failure is almost the same as that of hand stitching. As an alternative, staples are used. Staples are used in various surgical sites such as skin, blood vessels, intestinal tract, bones, muscles, and organs. In addition, it is used by a method depending on the suture location, such as puncturing and stitching from outside the body into the skin, or indwelling in the living body after suturing a blood vessel, intestinal tract, organ or the like in the living body.
 上記ステープルの内、生体内に留置するステープルとしては、ステンレス鋼、チタン、タンタル等の金属及び当該金属の表面にアモルファス状のダイヤモンド様のカーボン膜を形成した、ヒト体内において不溶性のステープルが知られている(特許文献1参照)。また、皮膚、筋膜または内部器官上の創傷を閉鎖するため、ヒト体内で可溶性の金属材料で作製したステープルも知られている(特許文献2参照)。 Among the staples described above, staples that are indwelled in a living body include metals such as stainless steel, titanium, tantalum, and the like, and amorphous diamond-like carbon films formed on the surfaces of the metals, which are insoluble in the human body. (See Patent Document 1). In addition, a staple made of a metal material soluble in the human body in order to close a wound on the skin, fascia or internal organ is also known (see Patent Document 2).
特開平5-154189号公報JP-A-5-154189 特許第5036697号公報Japanese Patent No. 5036697
 上記特許文献1及び2に記載されているとおり、生体内に留置するステープルとしては、生体内で不溶性及び可溶性の両方が知られている。ところで、不溶性の材料は生体にとって異物になることから、術後長期間にわたり不溶性の材料を生体内に留置した場合、難治性の感染症が起こる場合がある。そのため、生体内に留置するステープルとしては、生体内で可溶性の材料で作製することが望ましいと考えられる。しかしながら、実際の医療の現場では、生体内に留置するステープルはチタン等の不溶性の材料で作製されたものがほとんどで、可溶性の材料で作製したステープルは殆ど用いられていないという問題がある。 As described in Patent Documents 1 and 2, both insoluble and soluble in vivo are known as staples to be placed in the living body. By the way, since an insoluble material becomes a foreign body for a living body, when an insoluble material is left in the living body for a long time after the operation, an intractable infection may occur. For this reason, it is considered that the staples placed in the living body are desirably made of a material that is soluble in the living body. However, in actual medical practice, most of the staples placed in the living body are made of an insoluble material such as titanium, and there is a problem that staples made of a soluble material are hardly used.
 本発明は、上記問題点を解決するためになされたもので、鋭意研究をおこなったところ、(1)生分解性の金属材料で作製したステープルを生体内に留置した場合、生体外から縫合した場合と異なり、ステープル全体が生体内成分により徐々に腐食する。その際に、ステープルの屈曲した箇所に生体組織を縫合するための力が集中するため、屈曲した箇所で破断し易くなること、(2)ステープルの2本の刺入部と縫合箇所を跨る架設部を連結するための連結部を、屈曲点を有しない湾曲部を含む形状に形成することで、生体組織を縫合するための力が分散されて特定箇所に力が集中しないため、ステープルが破断し難くなること、(3)架設部の少なくとも一部を、連結部の頂部と頂部を結んだ線より刺入部の先端側に位置するように形成することで、縫合箇所を2本の刺入部に加え架設部で押さえ付けることで縫合箇所を密着できること、を新たに見出した。 The present invention has been made in order to solve the above-mentioned problems. As a result of extensive research, (1) when a staple made of a biodegradable metal material is placed in a living body, it is sutured from outside the living body. Unlike the case, the entire staple is gradually corroded by in vivo components. At that time, since the force for suturing the living tissue concentrates on the bent portion of the staple, it is easy to break at the bent portion. By forming the connecting part for connecting the parts into a shape including a curved part that does not have a bending point, the force for suturing the living tissue is dispersed and the force does not concentrate at a specific location, so the staple breaks (3) By forming at least a part of the erection part so as to be positioned on the distal end side of the insertion part with respect to the line connecting the top part and the top part of the connection part, two stitches are formed. It was newly found that the sutured part can be brought into close contact by being pressed down by the installation part in addition to the entrance part.
 すなわち、本発明の目的は、生体内に留置した際に、破断し難い生体吸収性ステープルを提供することにある。 That is, an object of the present invention is to provide a bioabsorbable staple that is difficult to break when placed in a living body.
 本発明は以下に示す生体吸収性ステープルに関する。 The present invention relates to the following bioabsorbable staples.
(1)生分解性金属材料で形成したステープルであって、
 前記ステープルは、生体組織に刺し込む2本の刺入部、縫合箇所を跨る架設部、前記刺入部と前記架設部を連結する連結部を含み、
 前記連結部は、屈曲点を有しない湾曲部を含む形状に形成され、且つ、
 前記連結部の頂部と頂部を結んだ線より、前記架設部の少なくとも一部が刺入部の先端側に位置する生体吸収性ステープル。
(2)前記架設部の全てが、前記連結部の頂部と頂部を結んだ線より刺入部の先端側に位置する上記(1)に記載の生体吸収性ステープル。
(3)前記連結部のもっとも湾曲した部分が、曲率半径=0.275mm以上である上記(1)又は(2)に記載の生体吸収性ステープル。
(4)前記生分解性金属材料が、マグネシウムを主成分とする合金から選択される上記(1)~(3)の何れか一に記載の生体吸収性ステープル。
(5)前記生分解性金属材料の周りが、生分解性樹脂でコーティングされている上記(1)~(4)の何れか一に記載の生体吸収性ステープル。
(1) A staple formed of a biodegradable metal material,
The staple includes two insertion portions to be inserted into a living tissue, an erection portion that straddles a suture site, and a connection portion that connects the insertion portion and the erection portion,
The connecting portion is formed in a shape including a curved portion having no bending point, and
A bioabsorbable staple in which at least a part of the erection part is located on a distal end side of the insertion part from a line connecting the top part and the top part of the connection part.
(2) The bioabsorbable staple according to (1), wherein all of the erection portions are located on a distal end side of the insertion portion with respect to a line connecting the top portions of the connection portions.
(3) The bioabsorbable staple according to (1) or (2), wherein the most curved portion of the connecting portion has a radius of curvature of 0.275 mm or more.
(4) The bioabsorbable staple according to any one of (1) to (3), wherein the biodegradable metal material is selected from an alloy containing magnesium as a main component.
(5) The bioabsorbable staple according to any one of (1) to (4), wherein the biodegradable metal material is coated with a biodegradable resin.
 生体吸収性ステープルの連結部は、屈曲点を有しない湾曲部を含む形状に形成されていることから、生体内に留置しても破断し難い。したがって、縫合箇所を長期間にわたり密着することができる。 Since the connecting portion of the bioabsorbable staple is formed in a shape including a curved portion having no bending point, it is difficult to break even if it is placed in the living body. Therefore, the stitched portion can be adhered over a long period of time.
 また、ステープルの連結部は屈曲点を有しない湾曲部を含む形状に形成されていることから、架設部の少なくとも一部を、連結部の頂部と頂部を結んだ線より刺入部の先端側に位置するように形成することができる。当該ステープルで縫合すると、縫合箇所を2本の刺入部に加え架設部で密着させることができるので、縫合箇所の密着効率を上げることができる。 Further, since the connecting portion of the staple is formed in a shape including a curved portion that does not have a bending point, at least a part of the erection portion is arranged on the distal end side of the insertion portion with respect to a line connecting the top portion and the top portion of the connecting portion. It can form so that it may be located in. When stitched with the staple, the stitched portion can be brought into close contact with the installation portion in addition to the two insertion portions, so that the close-contact efficiency of the stitched portion can be increased.
図1は、ステープル1の実施形態の少なくとも一例を説明する図である。FIG. 1 is a diagram illustrating at least one example of an embodiment of a staple 1. 図2は、「屈曲点」を説明するための図である。FIG. 2 is a diagram for explaining the “bending point”. 図3(A)~(D)は、屈曲点を有しない湾曲部を含む形状の例を示す図である。FIGS. 3A to 3D are diagrams showing examples of shapes including a curved portion having no bending point. 図4(A)~(C)は、ステープル1の実施形態の他の例を示す図である。4A to 4C are diagrams showing another example of the staple 1 embodiment. 図5(A)及び(B)はステープル1の実施形態に含まれない形状を示す図である。5A and 5B are views showing shapes that are not included in the embodiment of the staple 1. 図6(A)及び(B)は、架設部3と連結部4との境界を説明する図で、図6(C)は、架設部3の他の例を示す図である。6A and 6B are diagrams for explaining the boundary between the erection part 3 and the connecting part 4, and FIG. 6C is a diagram illustrating another example of the erection part 3. 図7は、ステープル1の実施形態の更に他の例を示す図である。FIG. 7 is a view showing still another example of the embodiment of the staple 1. 図8は、図面代用写真で、図8(A)は実施例1、図8(B)は実施例2、図8(C)は実施例3、図8(D)は実施例4、図8(E)は実施例5で、異なる直径(曲率半径)のステンレス製棒に線材を押し付けながら180°曲げた後の写真である。FIG. 8 is a drawing-substituting photograph, FIG. 8A is Example 1, FIG. 8B is Example 2, FIG. 8C is Example 3, FIG. 8D is Example 4, and FIG. 8 (E) is a photograph of Example 5 after bending by 180 ° while pressing a wire against a stainless steel rod having a different diameter (curvature radius). 図9は、図面代用写真で、図9(A)は実施例6で作製したステープルの写真、図9(B)は比較例1で作製したステープルの写真、図9(C)は腸管に穿刺した実施例6のステープルの写真、図9(D)は腸管に穿刺した比較例1のステープルの写真である。FIG. 9 is a drawing-substituting photograph, FIG. 9A is a photograph of the staple produced in Example 6, FIG. 9B is a photograph of the staple produced in Comparative Example 1, and FIG. 9C is a puncture in the intestinal tract. FIG. 9D is a photograph of the staple of Comparative Example 1 punctured in the intestinal tract. 図10は、図面代用写真で、図10(A)は実施例7の術後1週間のHE染色した切片の写真(20倍拡大)、図10(B)は実施例7の術後1週間のHE染色した切片の写真(200倍拡大)である。図10(C)は比較例2の術後1週間のHE染色した切片の写真(20倍拡大)、図10(D)は比較例2の術後1週間のHE染色した切片の写真(200倍拡大)である。FIG. 10 is a drawing-substituting photograph, FIG. 10 (A) is a photograph of a HE-stained section of a week after the operation of Example 7 (magnified 20 times), and FIG. 10 (B) is a week of the operation of Example 7 after one week. It is the photograph (200 time expansion) of the section | stain dye | stained HE. FIG. 10 (C) is a photograph of a HE-stained section 1 week after surgery in Comparative Example 2 (20-fold enlargement), and FIG. 10D is a photograph of a HE-stained section 1 week after surgery in Comparative Example 2 (200). Double magnification). 図11は、図面代用写真で、図11(A)は実施例7の術後2週間のHE染色した切片の写真(40倍拡大)、図11(B)は実施例7の術後2週間のHE染色した切片の写真(100倍拡大)である。図11(C)は比較例2の術後2週間のHE染色した切片の写真(40倍拡大)、図11(D)は比較例2の術後2週間のHE染色した切片の写真(100倍拡大)である。FIG. 11 is a drawing-substituting photograph, FIG. 11 (A) is a photograph of a HE-stained section 2 times after the operation of Example 7 (magnification 40 times), and FIG. 11 (B) is 2 weeks after the operation of Example 7. It is the photograph (100 time expansion) of the section | stain dye | stained HE. FIG. 11 (C) is a photograph of a HE-stained section of Comparative Example 2 two weeks after surgery (magnification 40 times), and FIG. 11D is a photograph of a HE-stained section of Comparative Example 2 two weeks after surgery (100). Double magnification). 図12は、図面代用写真で、図12(A)は実施例7の術後4週間のHE染色した切片の写真(100倍拡大)、図12(B)は実施例7の術後4週間のHE染色した切片の写真(400倍拡大)である。図12(C)は比較例2の術後4週間のHE染色した切片の写真(100倍拡大)、図12(D)は比較例2の術後4週間のHE染色した切片の写真(400倍拡大)である。FIG. 12 is a drawing-substituting photograph, FIG. 12 (A) is a photograph of a HE-stained section of 4 weeks after the operation of Example 7 (100 times magnification), and FIG. 12 (B) is 4 weeks after the operation of Example 7. It is the photograph (400 times expansion) of the section | stain dyed | stained HE. 12C is a photograph of a HE-stained section of Comparative Example 2 4 weeks after surgery (100 times magnification), and FIG. 12D is a photograph of a HE-stained section of Comparative Example 2 4 weeks after surgery (400). Double magnification).
 以下に、ステープルの実施形態について詳しく説明する。図1は、ステープルの実施形態の一例を説明する図である。図1に示すステープル1は、外科手術等により縫合が必要な箇所の生体組織に刺し込む2本の刺入部2、縫合箇所を跨る架設部3、刺入部2と架設部3を連結する2つの連結部4を含んでいる。 Hereinafter, embodiments of the staple will be described in detail. FIG. 1 is a diagram illustrating an example of a staple embodiment. A staple 1 shown in FIG. 1 connects two insertion portions 2 to be inserted into a living tissue where suture is necessary by a surgical operation or the like, an erection portion 3 straddling the suture location, and the insertion portion 2 and the erection portion 3. Two connecting portions 4 are included.
 連結部4は、屈曲点を有しない湾曲部を含む形状に形成されている。なお、本願において「屈曲点」とは、図2に示すように、線材を特定の箇所を中心に折り曲げた際の折り曲げ中心箇所5を意味し、折り曲げ中心箇所5を有しない滑らかな局面が続く湾曲部とは異なる。本願では、「屈曲点」を含まないことから、縫合箇所を密着するための力がステープルの特定箇所に集中し難くなり、その結果、生体内で腐食作用を受けても破断し難くなる。 The connecting part 4 is formed in a shape including a curved part having no bending point. In addition, in this application, as shown in FIG. 2, "bending point" means the bending center location 5 when a wire is bent around a specific location, and a smooth situation without the bending center location 5 continues. Different from the curved part. In the present application, since the “bending point” is not included, the force for bringing the sutured portion into close contact is less likely to be concentrated on the specific portion of the staple, and as a result, it is difficult to break even if it is corroded in vivo.
 また、本願の「屈曲点を有しない湾曲部を含む形状」とは、屈曲点を含まず、且つ、湾曲部を含むことで刺入部2と架設部3とを連結することができる全ての形状を意味する。例えば、図3(A)に示すように、連結部4の全体が滑らかに連続して同一方向に湾曲している形状、図3(B)に示すように、連結部4の一部又は全部が波状部分を含み、連結部4が全体としては同一方向に湾曲している形状、図3(C)に示すように、連結部4が直線部分と湾曲部分を含んでいる形状が挙げられる。なお、図示は省略するが、図3(B)に示す形状の連結部4の一部に直線部分を含んでいてもよい。また、図3(A)~(C)に示す形状の連結部4は、刺入部2からステープル1の内側方向に徐々に湾曲しているが、図3(D)に示すように、刺入部2からステープル1の外側方向に先ず湾曲し、次いで、ステープル1の内側方向に徐々に湾曲するようにしてもよい。また、図示は省略するが、図3(D)に示す形状の連結部4の場合も、図3(B)に示すように一部又は全部が波状部分、図3(C)に示すような直線部分を含んでいてもよい。なお、図3は、本願のステープル1の具体的形状の例示であって、図3に示す例に限定されるものではない。「屈曲点を有しない湾曲部を含む形状」であれば、図示しない形状であってもよい。 In addition, the “shape including a bending portion that does not have a bending point” in the present application refers to all shapes that do not include a bending point and can connect the insertion portion 2 and the erection portion 3 by including the bending portion. Means shape. For example, as shown in FIG. 3 (A), the whole connecting portion 4 is smoothly and continuously curved in the same direction, and as shown in FIG. 3 (B), part or all of the connecting portion 4 is curved. Includes a wavy portion, and the connecting portion 4 is curved in the same direction as a whole, and as shown in FIG. 3C, the connecting portion 4 includes a straight portion and a curved portion. In addition, although illustration is abbreviate | omitted, a linear part may be included in a part of connection part 4 of the shape shown to FIG. 3 (B). 3A to 3C are gradually curved from the insertion portion 2 toward the inside of the staple 1, but as shown in FIG. 3D, the connection portion 4 is gradually curved. It is also possible to first bend from the insertion portion 2 toward the outside of the staple 1 and then gradually bend toward the inside of the staple 1. Although not shown in the figure, the connection portion 4 having the shape shown in FIG. 3D is also partially or entirely wavy as shown in FIG. 3B, as shown in FIG. It may include a straight line portion. FIG. 3 is an illustration of a specific shape of the staple 1 of the present application, and is not limited to the example shown in FIG. As long as it is “a shape including a curved portion having no bending point”, a shape not shown may be used.
 なお、実施形態に係るステープル1は、ステープラーのカートリッジに入れ、ステープル1を押し出して生体組織に穿刺する。図3(D)に示す形状のステープル1も使用可能ではあるが、連結部4がステープル1の外側にせり出していると、刺入部2がカートリッジの壁面から離れてしまう。そのため、穿刺時の安定性との観点からは、図3(A)~(C)に示すように、連結部4が刺入部2からステープル1の内側方向に徐々に湾曲している形状の方が好ましい。 The staple 1 according to the embodiment is put into a stapler cartridge, and the staple 1 is pushed out to puncture a living tissue. Although the staple 1 having the shape shown in FIG. 3D can also be used, when the connecting portion 4 protrudes outside the staple 1, the insertion portion 2 is separated from the wall surface of the cartridge. Therefore, from the viewpoint of stability at the time of puncturing, as shown in FIGS. 3A to 3C, the connecting portion 4 is gradually curved from the insertion portion 2 toward the inside of the staple 1. Is preferred.
 架設部3は、一方の連結部4の頂部41及び他方の連結部4の頂部41を結んだ線(図1中の点線)より、少なくとも一部が刺入部2の先端21側に位置している。なお、本願において、「頂部」とは、図1に示すとおり、刺入部2の2つの先端21を結んだ線から最も距離Hがある箇所を意味する。 At least a part of the erection part 3 is located on the distal end 21 side of the insertion part 2 from the line (dotted line in FIG. 1) connecting the top part 41 of the one connection part 4 and the top part 41 of the other connection part 4. ing. In addition, in this application, a "top part" means the location which has the distance H most from the line | wire which connected the two front-end | tips 21 of the insertion part 2, as shown in FIG.
 図1は、架設部3の全てが頂部41と頂部41を結んだ線より刺入部2の先端21側に位置している例を示しているが、上記の架設部3と頂部41の位置関係を満たせば特に制限は無い。図4は、ステープル1の実施形態の他の例を示しており、図4(A)は架設部3を波形状で形成し、波の一つが頂部41を結んだ線より先端21とは反対側に突出、図4(B)は架設部3を波形状で形成し、波の全てが頂部41を結んだ線より先端21側に突出、図4(C)は架設部3を波形状で形成し、複数の波が頂部41を結んだ線より先端21とは反対側に突出、している例を示している。架設部3の形状は、縫合する箇所の形状に応じて適宜決めればよい。 FIG. 1 shows an example in which all of the erection part 3 is located on the distal end 21 side of the insertion part 2 with respect to the line connecting the top part 41 and the top part 41, but the position of the erection part 3 and the top part 41 described above. There are no restrictions as long as the relationship is satisfied. FIG. 4 shows another example of the embodiment of the staple 1, and FIG. 4 (A) shows that the construction part 3 is formed in a wave shape, and one of the waves is opposite to the tip 21 from the line connecting the top parts 41. 4B, the erection part 3 is formed in a wave shape, and all of the waves protrude toward the tip 21 side from the line connecting the top parts 41, and FIG. An example is shown in which a plurality of waves protrude from the line connecting the top portions 41 to the side opposite to the tip 21. What is necessary is just to determine the shape of the construction part 3 suitably according to the shape of the location to sew.
 また、図5は、ステープル1の実施形態に含まれない例を示している。当該技術分野においては、図5(A)に示す略U字型や、図5(B)に示す略コ字状のステープルが知られている。しかしながら、図5(A)及び(B)に示す形状のステープルは、連結部4の頂部41と頂部41を結んだ線より、架設部3のいずれの部分も刺入部2の先端21側に位置していないことから、ステープル1の実施形態には含まれない。 FIG. 5 shows an example not included in the embodiment of the staple 1. In this technical field, a substantially U-shaped staple shown in FIG. 5A and a substantially U-shaped staple shown in FIG. 5B are known. However, in the staple of the shape shown in FIGS. 5A and 5B, any part of the erection part 3 is closer to the distal end 21 side of the insertion part 2 than the line connecting the top part 41 and the top part 41 of the connecting part 4. It is not included in the staple 1 embodiment because it is not located.
 図6は、架設部3と連結部4との境界を説明する図である。図6(A)に示すように、連結部4の全体が滑らかに同一方向に湾曲している場合、連結部4の任意の2点を円弧とする仮想円の中心点Rは、何れもステープル1の内側になる。連結部4が直線部分を含んでいる場合でも、Rがステープル1の外側になることは無い。一方、架設部3の一部は、頂部41と頂部41を結んだ線より先端21側にあるため、任意の2点を円弧とする仮想円の中心点Rはステープル1の外側になる部分がある。架橋部3と連結部4との境界は、円弧の中心点が反転する箇所と定義すればよい。一方、図6(B)に示すように、連結部4が波状部分を含む場合、仮想円の中心点Rはステープル1の内側及び外側の両方に位置する。その場合、円弧の中心点がステープル1の内側から外側に反転する最後の箇所を架設部3と連結部4との境界と定義すればよい。なお、架設部3と連結部4との境界は上記のように定義されるので、例えば、図6(C)に示すように、架設部3が略U字状の形状もステープル1の実施形態に含まれる。 FIG. 6 is a diagram for explaining the boundary between the erection part 3 and the connection part 4. As shown in FIG. 6A, when the entire connecting portion 4 is smoothly curved in the same direction, the center point R of the virtual circle having an arc at two arbitrary points of the connecting portion 4 is a staple. 1 inside. Even when the connecting portion 4 includes a straight portion, R does not become outside the staple 1. On the other hand, since a part of the erection part 3 is on the tip 21 side from the line connecting the top part 41 and the top part 41, the center point R of the virtual circle having an arc of any two points is the part that is outside the staple 1. is there. What is necessary is just to define the boundary of the bridge | bridging part 3 and the connection part 4 as a location where the center point of a circular arc reverses. On the other hand, as shown in FIG. 6B, when the connecting portion 4 includes a wave-like portion, the center point R of the virtual circle is located both inside and outside the staple 1. In that case, what is necessary is just to define the last location where the center point of a circular arc reverses from the inner side of the staple 1 to the outer side as the boundary between the erection part 3 and the connection part 4. Since the boundary between the erection part 3 and the connection part 4 is defined as described above, for example, as shown in FIG. include.
 図7は、ステープル1の実施形態の更に他の例を示している。ステープル1の刺入部2は、生体組織に穿刺し易くするため、ほぼ直線状となっている。そのため、刺入部2を穿刺した後に連結部4が生体組織に当接すると、ステープル1がほぼ直線から徐々に曲がるためステープル1を生体組織に穿刺し難くなる。そのため、図7に示すように、架設部3の少なくとも一部を、連結部4の頂部41と頂部41を結んだ線より更に刺入部2の先端21側である刺入部2と連結部4の境界24を結んだ線25より刺入部2の先端21側に位置するように形成してもよい。図7に示す実施形態の場合、架設部3が縫合箇所により当接し易くなることから、縫合箇所の密着効率を上げることができる。刺入部2と連結部4との境界は、刺入部2が湾曲し始める場所とすればよい。 FIG. 7 shows still another example of the embodiment of the staple 1. The insertion portion 2 of the staple 1 is substantially linear in order to make it easier to puncture a living tissue. Therefore, when the connecting portion 4 comes into contact with the living tissue after puncturing the insertion portion 2, the staple 1 is gradually bent from a substantially straight line, so that it is difficult to puncture the living tissue. Therefore, as shown in FIG. 7, at least a part of the erection part 3 is connected to the insertion part 2 and the connection part which are further on the tip 21 side of the insertion part 2 from the line connecting the top part 41 and the top part 41 of the connection part 4. 4 may be formed so as to be positioned closer to the distal end 21 side of the insertion portion 2 than the line 25 connecting the boundaries 24 of the four. In the case of the embodiment shown in FIG. 7, the erection part 3 is more likely to come into contact with the stitched portion, so that the adhesion efficiency of the stitched portion can be increased. The boundary between the insertion part 2 and the connection part 4 may be a place where the insertion part 2 begins to bend.
 上記のとおり、各々の実施形態に示すステープル1は、屈曲点を有さないことを特徴としているが、ステープル1の特定箇所に負荷がかからないようにするためには、湾曲部の曲率半径を大きくすることが好ましい。なお、本願において「曲率半径」とは、連結部4の湾曲部の任意の2点を円弧とする仮想円の半径を意味する。連結部4の曲率半径は、0.1mm以上が好ましく、0.275mm以上がより好ましく、0.4mm以上が更に好ましい。また、連結部4と架設部3、連結部4と刺入部2との境界部分についても、上記と同様の曲率半径とすることが好ましい。連結部4を波形状にする場合は、上記の曲率半径となるように、振幅を小さくすればよい。なお、架設部3を波形状とする場合も、上記と同様の曲率半径となるようにすればよい。 As described above, the staple 1 shown in each embodiment is characterized by having no bending point. However, in order to prevent a load from being applied to a specific portion of the staple 1, the curvature radius of the curved portion is increased. It is preferable to do. In the present application, the “curvature radius” means a radius of an imaginary circle having an arc at two arbitrary points of the curved portion of the connecting portion 4. The radius of curvature of the connecting portion 4 is preferably 0.1 mm or more, more preferably 0.275 mm or more, and still more preferably 0.4 mm or more. Moreover, it is preferable to also set the curvature radius similar to the above also about the boundary part of the connection part 4 and the installation part 3, and the connection part 4 and the insertion part 2. FIG. When the connecting portion 4 is wave-shaped, the amplitude may be reduced so as to have the above-described curvature radius. In addition, what is necessary is just to make it become the same curvature radius as the above also when the construction part 3 is made into a waveform.
 また、各々の実施形態に示すステープル1が用いられる縫合箇所に特に制限は無く、縫合箇所の厚み等に応じた大きさのステープルを用いればよい。ステープル1の大きさは、例えば、縦幅(刺入部2の先端から架設部3の距離)が2~5mm(生体組織に穿刺した後の縦幅は0.5mm~3mm)、横幅(刺入部2と刺入部2との間隔)が1mm~5mm程度のものが例示できるが、上記のとおり、サイズについては、縫合箇所に応じて適宜調整すればよい。 In addition, there is no particular limitation on the stitching site where the staple 1 shown in each embodiment is used, and a staple having a size corresponding to the thickness of the stitching site may be used. The staple 1 has, for example, a vertical width (distance from the distal end of the insertion portion 2 to the erection portion 3) of 2 to 5 mm (a vertical width after puncturing the living tissue is 0.5 mm to 3 mm), and a horizontal width (puncture The distance between the insertion portion 2 and the insertion portion 2) can be exemplified by about 1 mm to 5 mm. However, as described above, the size may be appropriately adjusted according to the suture location.
 各々の実施形態に示すステープル1は、生体内に留置した際に生分解する金属材料であれば、特に制限は無い。例えば、生分解性金属材料としては、純マグネシウムまたはマグネシウム合金、純カルシウムまたはカルシウム合金、純亜鉛または亜鉛合金などが使用される。好ましくは、純マグネシウムまたはマグネシウム合金である。マグネシウム合金としては、マグネシウムを主成分とし、H、C、N、O、Na、P、K、Ca、Fe、B、Al、Si、V、Cr、Mn、Znからなる体内必須元素、もしくはSc、Y、La、Ce、Nd、Sm、Gd、Tb、Dy、Ybからなる希土類元素から選択される少なくとも1つの元素を含有するものが好ましい。 The staple 1 shown in each embodiment is not particularly limited as long as it is a metal material that biodegrades when placed in the living body. For example, as the biodegradable metal material, pure magnesium or a magnesium alloy, pure calcium or a calcium alloy, pure zinc or a zinc alloy, or the like is used. Preferred is pure magnesium or a magnesium alloy. As a magnesium alloy, magnesium is a main component, H, C, N, O, Na, P, K, Ca, Fe, B, Al, Si, V, Cr, Mn, Zn. , Y, La, Ce, Nd, Sm, Gd, Tb, Dy, and Yb containing at least one element selected from rare earth elements.
 また、各々の実施形態に示すステープル1は、生分解性金属材料のみで作製してもよいが、生分解性金属材料の周りを、生分解性樹脂でコーティングしてもよい。生分解性樹脂でコーティングすることで、生体内に留置した際のステープル1の腐食の進行を調整することができる。生分解性樹脂としては、生体内で酵素的、非酵素的に分解され、分解物が毒性を示さないものであれば特に限定されない。例えば、ポリ乳酸、ポリグリコール酸、ポリ乳酸-ポリグリコール酸共重合体、ポリカプロラクトン、ポリ乳酸-ポリカプロラクトン共重合体、ポリオルソエステル、ポリホスファゼン、ポリリン酸エステル、ポリヒドロキシ酪酸、ポリリンゴ酸、ポリα-アミノ酸、コラーゲン、ゼラチン、ラミニン、ヘパラン硫酸、フィブロネクチン、ビトロネクチン、コンドロイチン硫酸、ヒアルロン酸、ポリヒドロキシブチレイト吉草酸、ポリサリチル酸、ポリペプチド、多糖類、キチン、キトサンなどが挙げられる。 Further, the staple 1 shown in each embodiment may be made of only a biodegradable metal material, but the biodegradable metal material may be coated with a biodegradable resin. By coating with a biodegradable resin, the progress of corrosion of the staple 1 when placed in the living body can be adjusted. The biodegradable resin is not particularly limited as long as it is enzymatically or non-enzymatically decomposed in vivo and the decomposed product does not exhibit toxicity. For example, polylactic acid, polyglycolic acid, polylactic acid-polyglycolic acid copolymer, polycaprolactone, polylactic acid-polycaprolactone copolymer, polyorthoester, polyphosphazene, polyphosphoric acid ester, polyhydroxybutyric acid, polymalic acid, poly Examples include α-amino acids, collagen, gelatin, laminin, heparan sulfate, fibronectin, vitronectin, chondroitin sulfate, hyaluronic acid, polyhydroxybutyrate valeric acid, polysalicylic acid, polypeptides, polysaccharides, chitin, and chitosan.
 また、生分解性金属材料、又は生分解性金属材料をコーティングしている生分解性樹脂は、生理活性物質を担持しているものであってもよい。生理活性物質は、生分解性金属材料又は生分解性樹脂の表面に担持されていれば特に制限は無く、例えば、生理活性物質を溶剤等に溶解し、塗布すればよい。 Further, the biodegradable metal material or the biodegradable resin coated with the biodegradable metal material may carry a physiologically active substance. The physiologically active substance is not particularly limited as long as it is supported on the surface of the biodegradable metal material or biodegradable resin. For example, the physiologically active substance may be dissolved in a solvent or the like and applied.
 生理活性物質としては、治療等に用いられている公知の医薬品であれば特に制限は無い。例えば、体内に留置するステープルは生体にとっては異物であるため、抗炎症剤、抗生物質、抗アレルギー剤等を担持することで、術後の炎症等を抑制することができる。また、縫合箇所が血管であれば止血剤等、縫合箇所が癌であれば抗がん剤等を担持してもよい。 Physiologically active substance is not particularly limited as long as it is a known drug used for treatment or the like. For example, since a staple placed in the body is a foreign substance for a living body, post-operative inflammation or the like can be suppressed by carrying an anti-inflammatory agent, an antibiotic, an antiallergic agent, or the like. In addition, a hemostatic agent or the like may be carried if the suture site is a blood vessel, and an anticancer agent or the like may be carried if the suture site is cancer.
 各々の実施形態に示すステープル1は、上記のとおり、連結部4が屈曲点を有しない湾曲部を含む形状に形成されていれば、製造方法は特に制限は無い。例えば、少なくとも連結部4及び架設部3の形状に対応した金型を作製し、生分解性金属材料で作製した薄板をプレス成型すればよい。又は、刺入部2、連結部4及び架設部3の形状の金型を作製し、溶融した生分解性金属材料を射出成形すればよい。なお、刺入部2の先端部分は、生体組織に穿刺し易くするためにテーパー状にしてもよい。先端をテーパー状にするためには、プレスや射出成形用の鋳型を調整、又はプレス等で作製したステープをせん断もしくは研削すればよい。 As described above, the manufacturing method of the staple 1 shown in each embodiment is not particularly limited as long as the connecting portion 4 is formed in a shape including a curved portion having no bending point. For example, a metal mold corresponding to at least the shapes of the connecting part 4 and the erection part 3 is produced, and a thin plate made of a biodegradable metal material may be press-molded. Or the metal mold | die of the shape of the insertion part 2, the connection part 4, and the installation part 3 should be produced, and the melted biodegradable metal material should just be injection-molded. In addition, you may make the front-end | tip part of the insertion part 2 into a taper shape in order to make it easy to puncture a biological tissue. In order to make the tip tapered, a press or injection molding mold may be adjusted, or a staple produced by pressing or the like may be sheared or ground.
 各々の実施形態に示すステープル1は、公知の生体組織用のステープラーのカートリッジにセットして用いればよい。なお、各々の実施形態に示すステープル1は、連結部4が架設部3より刺入部2の先端側に位置しているため、カートリッジの連結部4に当接する部分が直線形状であると連結部の少なくとも一部は当該部分から離れることになる。そのため、ステープラーのステープルを押圧する部分が従来のコ字状のものを用いると、連結部4の頂部41に押圧力が集中してしまう恐れがある。そのため、各々の実施形態に示すステープル1を用いるステープラーの押圧部は、連結部4と架設部3に適合する形状とすることが好ましい。 The staple 1 shown in each embodiment may be set in a known stapler cartridge for living tissue. In addition, the staple 1 shown in each embodiment is connected when the connecting portion 4 is positioned on the distal end side of the insertion portion 2 with respect to the erection portion 3, so that the portion contacting the connecting portion 4 of the cartridge is linear. At least a part of the part is separated from the part. For this reason, if a conventional U-shaped portion that presses the staple of the stapler is used, the pressing force may concentrate on the top 41 of the connecting portion 4. Therefore, it is preferable that the pressing part of the stapler using the staple 1 shown in each embodiment has a shape that fits the connecting part 4 and the erection part 3.
 以下に実施例を掲げ、実施形態を具体的に説明するが、この実施例は単にその具体的な態様の参考のために提供されているものである。これらの例示は本願のステープル1の実施形態の特定の具体的な態様を説明するためのものであるが、本願で開示する実施形態の範囲を限定したり、あるいは制限することを表すものではない。 Hereinafter, embodiments will be described in detail with reference to examples, but these examples are provided merely for reference of specific modes. These illustrations are intended to illustrate certain specific aspects of the staple 1 embodiment of the present application, but do not limit or limit the scope of the embodiments disclosed herein. .
<実施例1~5>
[合金線材の作製]
 マグネシウム(Mg)、ネオジウム(Nd)、イットリウム(Y)及びジルコニウム(Zr)を、重量%で95.6%Mg-3.0%Nd-1.0%Y-0.4%Zrとなるように、それぞれの純金属を高周波誘導加熱用グラファイト坩堝に入れ、高周波溶解炉チャンバー内の高周波コイル内部に設置した。次に、チャンバー内を真空引きした後、大気圧になるまでヘリウムガスを充填し、坩堝を750℃まで加熱し、坩堝内の金属が全て溶融するのを確認した上で10分間保持し、その後、直ちに坩堝内の溶融物を予め高周波コイルの前面に設置しておいた円柱タイプの銅製鋳型に鋳込んだ。一定時間冷却した後、この鋳型から円柱状の上記合金インゴットを得た。
<Examples 1 to 5>
[Production of alloy wire]
Magnesium (Mg), Neodymium (Nd), Yttrium (Y) and Zirconium (Zr) will be 95.6% Mg-3.0% Nd-1.0% Y-0.4% Zr by weight%. In addition, each pure metal was placed in a graphite crucible for high frequency induction heating and placed inside a high frequency coil in a high frequency melting furnace chamber. Next, after evacuating the chamber, it is filled with helium gas until atmospheric pressure is reached, the crucible is heated to 750 ° C., and after confirming that all the metal in the crucible has melted, it is held for 10 minutes. Immediately, the melt in the crucible was cast into a cylindrical copper mold that had been installed in front of the high-frequency coil. After cooling for a certain period of time, the above-mentioned cylindrical alloy ingot was obtained from this mold.
 得られた合金インゴットは、温度400℃、押出し比15、押出し速度60mm/minの条件で熱間押出し成形し、外径17mmの棒材となるように加工した。そして、この合金棒材からビレット(外径10mm×長さ25mm)を切り出し、温度400℃、押出し比28の条件で熱間押出し成形を行い外径1.9mmの合金線材を得た。 The obtained alloy ingot was hot-extruded under conditions of a temperature of 400 ° C., an extrusion ratio of 15 and an extrusion speed of 60 mm / min, and processed into a rod having an outer diameter of 17 mm. A billet (outer diameter 10 mm × length 25 mm) was cut out from this alloy bar, and hot extrusion was performed under the conditions of a temperature of 400 ° C. and an extrusion ratio of 28 to obtain an alloy wire having an outer diameter of 1.9 mm.
 次に、合金線材を引き抜きダイスに挿入し、常温で引抜き加工を行った。引抜き加工の前後の合金線断面の減面率は30%以下となるように調整し、引抜き加工後には400℃×30minの焼鈍を行った。そして、合金線材の線径が0.25mmになるまで、引抜き加工、焼鈍を繰り返し行った。 Next, the alloy wire was inserted into a drawing die and drawn at room temperature. The area reduction rate of the alloy wire cross section before and after the drawing process was adjusted to 30% or less, and after the drawing process, annealing was performed at 400 ° C. for 30 minutes. Then, drawing and annealing were repeated until the wire diameter of the alloy wire became 0.25 mm.
 得られた線径0.25mmの合金線材を長さ25mmに切断し、以下の直径(曲率半径)のステンレス製棒に押し付けながら180°曲げた。
・実施例1:直径0.2mm(曲率半径=0.1mm)
・実施例2:直径0.55mm(曲率半径=0.275mm)
・実施例3:直径0.8mm(曲率半径=0.4mm)
・実施例4:直径1.0mm(曲率半径=0.5mm)
・実施例5:直径1.5mm(曲率半径=0.75mm)
The obtained alloy wire having a wire diameter of 0.25 mm was cut to a length of 25 mm and bent 180 ° while being pressed against a stainless steel rod having the following diameter (curvature radius).
Example 1: Diameter 0.2 mm (curvature radius = 0.1 mm)
Example 2: Diameter 0.55 mm (curvature radius = 0.275 mm)
-Example 3: Diameter 0.8mm (curvature radius = 0.4mm)
Example 4: Diameter 1.0 mm (curvature radius = 0.5 mm)
Example 5: Diameter 1.5 mm (curvature radius = 0.75 mm)
 図8(A)は実施例1、図8(B)は実施例2、図8(C)は実施例3、図8(D)は実施例4、図8(E)は実施例5で、180°曲げた後の写真である。なお、試料は各々3本作製して、上記の曲率半径で曲げた。表1に示すように、180°曲げた際に、実施例1の試料(合金線材)は曲げ加工部に亀裂が認められたが(破断はしていない)、実施例2~5の試料は曲げ加工部に亀裂は認められなかった。 8A is Example 1, FIG. 8B is Example 2, FIG. 8C is Example 3, FIG. 8D is Example 4, and FIG. 8E is Example 5. It is a photograph after bending 180 degrees. Three samples were prepared and bent with the above-mentioned curvature radius. As shown in Table 1, when the sample of Example 1 (alloy wire) was bent by 180 °, cracks were observed in the bent portion (not broken), but the samples of Examples 2 to 5 No cracks were observed in the bent part.
[浸漬実験]
 次に、生体内を模した浸漬実験系を作製し、実施例1~5の試料を浸漬実験系に浸漬した際の腐食変化について調べた。
 先ず、実施例1~5の試料を、0.5%硝酸水溶液に20秒間浸漬し、酸洗浄を行った後、純水、アセトンの順で超音波洗浄を各1分間施し、乾燥した。
 次に、牛血清(ニュージーランド産;Thermo Fisher Scientific社製Gibco)10mlを試験管に入れて浸漬実験系を作製した。そして、上記処理を施した試料を試験管に入れ、37℃に保たれた恒温槽内で試験管を保持し、浸漬時間3、6、9hで腐食状態を観察した。結果を表1に示す。浸漬時間が進むにつれ曲げ部での腐食破断が生じ、曲率半径が小さくなるほどその傾向が強く見受けられた。しかしながら、曲率半径=0.4mm以上では特に大きな差は見受けられなかった。
[Immersion experiment]
Next, an immersion experiment system simulating the inside of a living body was prepared, and the corrosion change when the samples of Examples 1 to 5 were immersed in the immersion experiment system was examined.
First, the samples of Examples 1 to 5 were immersed in a 0.5% nitric acid aqueous solution for 20 seconds, acid-washed, then subjected to ultrasonic washing for 1 minute each in the order of pure water and acetone, and dried.
Next, 10 ml of bovine serum (New Zealand; Thermo Fisher Scientific Gibco) was placed in a test tube to prepare an immersion experiment system. And the sample which performed the said process was put into the test tube, the test tube was hold | maintained in the thermostat kept at 37 degreeC, and the corrosion state was observed by immersion time 3,6,9h. The results are shown in Table 1. As the dipping time progressed, corrosion fracture occurred at the bent part, and this tendency was strongly observed as the radius of curvature decreased. However, no significant difference was observed when the radius of curvature was 0.4 mm or more.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
[穿刺実験]
<実施例6>
 上記実施例1~5に記載と同様の手順で得られた線径0.25mmの合金線材を、プレス加工により3mm(左右の刺入部2と連結部4の境界24を結んだ距離)×2.5mm(刺入部2と連結部4の頂部41までの長さ)のステープル形状に加工した。ステープルの刺入部2の先端は、刺入方向に対しステープル内側に向かって45度の角度でテーパー加工を施した。また、連結部4の曲率半径は0.5mmとした。架設部3の長さは2.5mmであった。次に、直径0.5mmのステンレス製棒を加工したステープルの架設部3に押付けることによって、架設部4が連結部4の頂部41より刺入部2の先端21側に曲率半径0.25mmの凹みを有するステープルを作製した。図9(A)は作製したステープルの写真である。
[Puncture experiment]
<Example 6>
An alloy wire having a wire diameter of 0.25 mm obtained by the same procedure as described in Examples 1 to 5 above is 3 mm (distance connecting the left and right insertion portions 2 and the connecting portion 4 boundary 24) by pressing. × It was processed into a staple shape of 2.5 mm (length to the insertion portion 2 and the top portion 41 of the connecting portion 4). The tip of the staple insertion portion 2 was tapered at an angle of 45 degrees toward the inside of the staple with respect to the insertion direction. Moreover, the curvature radius of the connection part 4 was 0.5 mm. The length of the erection part 3 was 2.5 mm. Next, by pressing a stainless steel rod having a diameter of 0.5 mm against the machined staple erection part 3, the erection part 4 has a radius of curvature of 0.25 mm from the top part 41 of the coupling part 4 to the distal end 21 side of the insertion part 2. Staples having indentations were prepared. FIG. 9A is a photograph of the produced staple.
 次に、作製したステープルを、豚肉を詰めた腸管に穿刺した。図9(C)は、腸管に穿刺したステープルの写真である。 Next, the produced staple was punctured into the intestinal tract filled with pork. FIG. 9C is a photograph of staples punctured in the intestinal tract.
<比較例1>
 実施例6において、直径0.5mmのステンレス製棒をステープルの架設部3に押付けず、プレス加工した状態のステープルを比較例1とした以外は、実施例6と同様に腸管に穿刺した。図9(B)は比較例1のステープルの写真、図9(D)は腸管に穿刺したステープルの写真である。
<Comparative Example 1>
In Example 6, the intestinal tract was punctured in the same manner as in Example 6 except that the stainless steel bar having a diameter of 0.5 mm was not pressed against the erection part 3 of the staple and the staple in the pressed state was changed to Comparative Example 1. FIG. 9B is a photograph of the staple of Comparative Example 1, and FIG. 9D is a photograph of the staple punctured in the intestinal tract.
 図9(A)~(D)から明らかなように、架設部が連結部頂部より刺入部先端側に位置するステープルは、縫合箇所に密着していることが確認された。一方、比較例1のステープルは連結部で止まり、架設部が縫合箇所に密着するに至らなかった。
 以上の結果より、ステープルの連結部が屈曲点を有しない湾曲部を含む形状に形成されると、生体内で破断し難くなり、更に、連結部の頂部と頂部を結んだ線より架設部の少なくとも一部が刺入部の先端側に位置することで、縫合箇所を長期間にわたり密着できることが明らかとなった。
As is clear from FIGS. 9A to 9D, it was confirmed that the staple having the erected portion positioned closer to the distal end side of the insertion portion than the top of the connecting portion was in close contact with the stitched portion. On the other hand, the staple of Comparative Example 1 stopped at the connecting portion, and the erection portion did not come into close contact with the stitched portion.
From the above results, when the connecting portion of the staple is formed into a shape including a curved portion that does not have a bending point, it is difficult to break in vivo, and further, the erection portion of the construction portion is connected to the line connecting the top portion and the top portion of the connecting portion. It has been clarified that at least a part is located on the distal end side of the insertion portion, so that the sutured portion can be adhered for a long period of time.
[動物体内での縫合実験]
<実施例7>
 実施例1の原料に代え、マグネシウム(Mg)、レアアース(RE;Ndを主成分とするミッシュメタル)、イットリウム(Y)を、重量%で96%Mg-3.0%RE-1.0%Yとなるように用いた以外は、実施例1と同様の手順で合金線材を作製し、次いで、線径0.25mmの線材を、プレス加工により3mm(左右の刺入部2と連結部4の境界24を結んだ距離)×2.5mm(刺入部2と連結部4の頂部41までの長さ)のステープル形状に加工した。ステープルの刺入部2の先端は、刺入方向に対しステープル内側に向かって45度の角度でテーパー加工を施した。
 次に、作製したステープルを用い、以下の手順により動物体内で縫合を行い病理所見の検討を行った。
(1)全身麻酔下で豚3頭を開腹し、回腸末端から50cmの部位を縫合器(エチコン(ジョンソン・エンド・ジョンソン)社製;Powered ECHELON FLEX)を用いて小腸機械縫合した。
(2)術後、1週間、2週間、4週間飼育した後開腹し、縫合部周囲の病理所見を観察した。病理所見は、縫合部の周囲の肉眼観察と、HE染色により観察した。HE染色は、以下の手順で行った。
(a)研磨標本を脱樹脂後、水洗した。
(b)ワイゲルト鉄ヘマトキシリン液に60分浸漬した。
(c)水洗後、エオジン液に7分浸漬した。
(d)エタノールで脱水し、キシレンで透徹後、封入した。
[Suture experiment in animal body]
<Example 7>
Instead of the raw material of Example 1, magnesium (Mg), rare earth (RE; misch metal containing Nd as a main component), and yttrium (Y) are 96% Mg-3.0% RE-1.0% by weight. An alloy wire was prepared in the same procedure as in Example 1 except that Y was used, and then a wire with a wire diameter of 0.25 mm was pressed into 3 mm (left and right insertion portions 2 and connecting portions 4). (Distance connecting the boundary 24) × 2.5 mm (the length from the insertion portion 2 to the top portion 41 of the connecting portion 4). The tip of the staple insertion portion 2 was tapered at an angle of 45 degrees toward the inside of the staple with respect to the insertion direction.
Next, using the prepared staples, sutures were performed in the animal body according to the following procedure, and pathological findings were examined.
(1) Three pigs were laparotomized under general anesthesia, and a small intestine machine suture was performed at 50 cm from the terminal ileum using a suture instrument (Ethicon (Johnson &Johnson); Powered ECHELON FLEX).
(2) After the operation, the abdomen was raised after 1 week, 2 weeks and 4 weeks, and the pathological findings around the sutured part were observed. The pathological findings were observed by visual observation around the sutured part and by HE staining. HE staining was performed according to the following procedure.
(A) The polished specimen was washed with water after resin removal.
(B) Immersion in Weigert's iron hematoxylin solution for 60 minutes.
(C) After washing with water, it was immersed in an eosin solution for 7 minutes.
(D) Dehydrated with ethanol, sealed with xylene, and sealed.
 図10(A)は術後1週間のHE染色した切片の写真(20倍拡大)、図10(B)は術後1週間のHE染色した切片の写真(200倍拡大)、図11(A)は術後2週間のHE染色した切片の写真(40倍拡大)、図11(B)は術後2週間のHE染色した切片の写真(100倍拡大)、図12(A)は術後4週間のHE染色した切片の写真(100倍拡大)、図12(B)は術後4週間のHE染色した切片の写真(400倍拡大)である。 FIG. 10 (A) is a photograph of a HE-stained section 1 week after surgery (20 times magnification), FIG. 10B is a photograph of a HE-stained section 1 week after surgery (200 times magnification), and FIG. 11 (A). ) Is a photograph of a HE-stained section 2 weeks after surgery (40 times magnification), FIG. 11B is a photograph of a HE-stained section 2 weeks after surgery (100 times magnification), and FIG. A photograph of a 4-week HE-stained section (100 times magnification) and FIG. 12 (B) are photographs of a 4-week post-surgery HE-stained section (400 times magnification).
<比較例2>
 実施例7のステープルに代えチタン製ステープル(エチコン(ジョンソン・エンド・ジョンソン)社製;ECR45W)を用い、実施例7とずらした位置(胃幽門部から50cm)で小腸機械縫合した以外は実施例7と同時に小腸縫合を行った。病理所見の観察は、実施例7と同様の手順で行った。
<Comparative Example 2>
Example except that titanium staple (Ethicon (Johnson &Johnson); ECR45W) was used instead of the staple of Example 7 and the small intestine machine was sutured at a position shifted from Example 7 (50 cm from the stomach pylorus). At the same time, small intestine suture was performed. The observation of the pathological findings was performed in the same procedure as in Example 7.
 図10(C)は術後1週間のHE染色した切片の写真(20倍拡大)、図10(D)は術後1週間のHE染色した切片の写真(200倍拡大)、図11(C)は術後2週間のHE染色した切片の写真(40倍拡大)、図11(D)は術後2週間のHE染色した切片の写真(100倍拡大)、図12(C)は術後4週間のHE染色した切片の写真(100倍拡大)、図12(D)は術後4週間のHE染色した切片の写真(400倍拡大)である。 FIG. 10 (C) is a photograph of a HE-stained section 1 week after surgery (20 times magnification), FIG. 10D is a photograph of a HE-stained section 1 week after surgery (200 times magnification), and FIG. 11 (C). ) Is a photograph of a HE-stained section 2 weeks after surgery (40 times magnification), FIG. 11 (D) is a photograph of a HE-stained section 2 weeks after surgery (100 times magnification), and FIG. 12 (C) is after surgery. A photograph of a 4-week HE-stained section (100-fold magnification) and FIG. 12D are photographs of a 4-week post-surgery HE-stained section (400-fold magnification).
 図10(A)~(D)及び肉眼観察から、術後1週間の時点で以下の病理所見が得られた。
(a)実施例7(Mgステープル)及び比較例2(Tiステープル)とも金属周囲に炎症細胞浸潤を認めたが、その影響は比較的狭い範囲にとどまっていた。
(b)Mgステープル及びTiステープルとも金属周囲の炎症は粘膜から漿膜面へ及んでいた。炎症の度合いは同程度であった。
(c)Tiステープルの方が、金属を中心に好中球・好酸球・リンパ球による炎症波及が強かった。
10A to 10D and macroscopic observation, the following pathological findings were obtained 1 week after the operation.
(A) In Example 7 (Mg staple) and Comparative Example 2 (Ti staple), inflammatory cell infiltration was observed around the metal, but the effect was limited to a relatively narrow range.
(B) In both Mg staple and Ti staple, the inflammation around the metal spread from the mucosa to the serosal surface. The degree of inflammation was similar.
(C) In the Ti staple, inflammation spread by neutrophils, eosinophils, and lymphocytes, mainly metal, was stronger.
 図11(A)~(D)及び肉眼観察から、術後2週間の時点で以下の病理所見が得られた。
(d)Mgステープル及びTiステープルとも比較的強い炎症細胞浸潤を標本全体に認めた。金属片とある程度離れていてるところにも炎症の波及が認められた。
(e)Mgステープル及びTiステープルとも金属周囲の炎症は粘膜から漿膜面へ及んでいた。炎症の度合いは同程度であった。
(f)Tiステープルの方が、金属を中心に好中球・好酸球・リンパ球による炎症波及が強かった。
From the results shown in FIGS. 11A to 11D and macroscopic observation, the following pathological findings were obtained at 2 weeks after the operation.
(D) Relatively strong inflammatory cell infiltration was observed in the entire specimen for both Mg staple and Ti staple. A spillover of inflammation was also observed at some distance from the metal piece.
(E) In both Mg staple and Ti staple, the inflammation around the metal spread from the mucosa to the serosal surface. The degree of inflammation was similar.
(F) Ti staples were more strongly affected by neutrophils, eosinophils and lymphocytes, mainly metal.
 図12(A)~(D)及び肉眼観察から、術後4週間の時点で以下の病理所見が得られた。
(g)Mgステープル及びTiステープルとも同程度に比較的強い炎症細胞浸潤を標本全体に認めた。また、金属片とある程度離れていてるところにも炎症の波及が認められた。
(h)Tiステープルの方が、金属を中心に好中球・好酸球・リンパ球による炎症波及が強かった。
12 (A) to 12 (D) and macroscopic observation, the following pathological findings were obtained at 4 weeks after the operation.
(G) A relatively strong inflammatory cell infiltration was observed in the whole specimen as well as both the Mg staple and the Ti staple. In addition, a spillover of inflammation was also observed at a distance from the metal piece.
(H) In the Ti staple, the inflammation spread by neutrophils, eosinophils, and lymphocytes, mainly metal, was stronger.
 実施例7及び比較例2より、Mgステープル及びTiステープルとも、術後1週間までは金属片の埋込に伴う局所の炎症性変化は、金属片のごく近傍(周囲のみ)に留まっており、炎症の度合いは両者で同程度であった。そして、術後4週間の間で、Mgステープル及びTiステープルとも、比較的強い炎症細胞浸潤を組織全体に認め、炎症は金属片から比較的離れたところにも認められた。しかしながら、Tiステープルと比較すると、Mgステープルの方が好中球・好酸球・リンパ球による炎症波及が弱いことが明らかとなった。以上の結果より、生体内に留置するステープルの材料として、生分解性金属材料の方が好ましいことを確認した。 From Example 7 and Comparative Example 2, in both the Mg staple and the Ti staple, the local inflammatory change accompanying the implantation of the metal piece remains only in the vicinity of the metal piece (only around) until one week after the operation. The degree of inflammation was similar in both cases. In the 4 weeks after the operation, both the Mg staple and the Ti staple showed a relatively strong inflammatory cell infiltration throughout the tissue, and inflammation was also observed at a relatively remote location from the metal piece. However, compared to Ti staples, Mg staples were found to have less inflammation spread by neutrophils, eosinophils, and lymphocytes. From the above results, it was confirmed that a biodegradable metal material is preferable as a material for staples placed in the living body.
 本願で開示する実施形態のステープルを用いると、縫合箇所を長期間にわたり密着することができる。したがって、医療機関における手術に有用である。 When the staple of the embodiment disclosed in the present application is used, the stitched portion can be adhered for a long period of time. Therefore, it is useful for surgery in a medical institution.

Claims (5)

  1.  生分解性金属材料で形成したステープルであって、
     前記ステープルは、生体組織に刺し込む2本の刺入部、縫合箇所を跨る架設部、前記刺入部と前記架設部を連結する連結部を含み、
     前記連結部は、屈曲点を有しない湾曲部を含む形状に形成され、且つ、
     前記連結部の頂部と頂部を結んだ線より、前記架設部の少なくとも一部が刺入部の先端側に位置する生体吸収性ステープル。
    A staple formed of a biodegradable metal material,
    The staple includes two insertion portions to be inserted into a living tissue, an erection portion that straddles a suture site, and a connection portion that connects the insertion portion and the erection portion,
    The connecting portion is formed in a shape including a curved portion having no bending point, and
    A bioabsorbable staple in which at least a part of the erection part is located on a distal end side of the insertion part from a line connecting the top part and the top part of the connection part.
  2.  前記架設部の全てが、前記連結部の頂部と頂部を結んだ線より刺入部の先端側に位置する請求項1に記載の生体吸収性ステープル。 2. The bioabsorbable staple according to claim 1, wherein all of the erection portions are located on a distal end side of the insertion portion with respect to a line connecting the top portions of the connection portions.
  3.  前記連結部のもっとも湾曲した部分が、曲率半径=0.275mm以上である請求項1又は2に記載の生体吸収性ステープル。 The bioabsorbable staple according to claim 1 or 2, wherein the most curved portion of the connecting portion has a curvature radius of 0.275 mm or more.
  4.  前記生分解性金属材料が、マグネシウムを主成分とする合金から選択される請求項1~3の何れか一項に記載の生体吸収性ステープル。 The bioabsorbable staple according to any one of claims 1 to 3, wherein the biodegradable metal material is selected from an alloy containing magnesium as a main component.
  5.  前記生分解性金属材料の周りが、生分解性樹脂でコーティングされている請求項1~4の何れか一項に記載の生体吸収性ステープル。
     
    The bioabsorbable staple according to any one of claims 1 to 4, wherein a periphery of the biodegradable metal material is coated with a biodegradable resin.
PCT/JP2016/080002 2015-10-09 2016-10-07 Bioabsorbable staple WO2017061616A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017544249A JP6823321B2 (en) 2015-10-09 2016-10-07 Bioabsorbable staple

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015201232 2015-10-09
JP2015-201232 2015-10-09

Publications (1)

Publication Number Publication Date
WO2017061616A1 true WO2017061616A1 (en) 2017-04-13

Family

ID=58487922

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/080002 WO2017061616A1 (en) 2015-10-09 2016-10-07 Bioabsorbable staple

Country Status (2)

Country Link
JP (1) JP6823321B2 (en)
WO (1) WO2017061616A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022238844A1 (en) * 2021-05-10 2022-11-17 Cilag Gmbh International Absorbable surgical staple comprising a coating
WO2022238846A1 (en) * 2021-05-10 2022-11-17 Cilag Gmbh International Bioabsorbable staple comprising mechanism for delaying the absorption of the staple

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4188236A1 (en) * 2020-07-29 2023-06-07 Magstape LLC Biometallic alloy surgical staples and methods

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06315486A (en) * 1992-09-23 1994-11-15 United States Surgical Corp Operating device method for surgical staples to attach objective to somatic tissue
JP2004154544A (en) * 2002-05-31 2004-06-03 Ethicon Endo Surgery Inc Method for locating and fixing tissue fastener
JP2005530559A (en) * 2002-06-21 2005-10-13 アンジオリンク・コーポレイション Improved management system and management method for wound sites
JP2006334412A (en) * 2005-06-02 2006-12-14 Tyco Healthcare Group Lp Staple capable of expandable backspan
JP2008536540A (en) * 2005-03-11 2008-09-11 タイコ ヘルスケア グループ エルピー Absorbable surgical fasteners
JP2009268909A (en) * 2008-05-09 2009-11-19 Tyco Healthcare Group Lp Variable compression surgical fastener apparatus
JP2011518017A (en) * 2008-04-21 2011-06-23 ミロ シムチャ Surgical stapling system

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06315486A (en) * 1992-09-23 1994-11-15 United States Surgical Corp Operating device method for surgical staples to attach objective to somatic tissue
JP2004154544A (en) * 2002-05-31 2004-06-03 Ethicon Endo Surgery Inc Method for locating and fixing tissue fastener
JP2005530559A (en) * 2002-06-21 2005-10-13 アンジオリンク・コーポレイション Improved management system and management method for wound sites
JP2008536540A (en) * 2005-03-11 2008-09-11 タイコ ヘルスケア グループ エルピー Absorbable surgical fasteners
JP2006334412A (en) * 2005-06-02 2006-12-14 Tyco Healthcare Group Lp Staple capable of expandable backspan
JP2011518017A (en) * 2008-04-21 2011-06-23 ミロ シムチャ Surgical stapling system
JP2009268909A (en) * 2008-05-09 2009-11-19 Tyco Healthcare Group Lp Variable compression surgical fastener apparatus

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022238844A1 (en) * 2021-05-10 2022-11-17 Cilag Gmbh International Absorbable surgical staple comprising a coating
WO2022238846A1 (en) * 2021-05-10 2022-11-17 Cilag Gmbh International Bioabsorbable staple comprising mechanism for delaying the absorption of the staple
WO2022238850A1 (en) * 2021-05-10 2022-11-17 Cilag Gmbh International Method for selecting a staple cartridge paired to the in situ environment

Also Published As

Publication number Publication date
JPWO2017061616A1 (en) 2018-08-09
JP6823321B2 (en) 2021-02-03

Similar Documents

Publication Publication Date Title
WO2017061616A1 (en) Bioabsorbable staple
EP2555689B1 (en) Bioabsorbable magnesium knots for securing surgical suture
CN105925847B (en) A kind of biodegradable zinc-base metal material and the ureterectasia stent obtained using the material
US10194904B2 (en) Surgical staple and method of use
CN213076762U (en) Degradable metal anastomosis nail
US20060052825A1 (en) Surgical implant alloy
US20060052824A1 (en) Surgical implant
US4602632A (en) Bio absorbable metal hemostatic clip
US8888842B2 (en) Implant made of a metallic material which can be resorbed by the body
TW200845949A (en) Endoluminal prosthesis
WO2017113657A1 (en) Iron-based alloy absorbable and implantable medical device for internal fixation
EP2781194A1 (en) Surgical instrument
JP2017501756A (en) Bioerodible magnesium alloy microstructure for internal prostheses
CN108378929A (en) With locator markers and preparation method thereof made of degradable metal
Gao et al. The mechanical property and corrosion resistance of Mg-Zn-Nd alloy fine wires in vitro and in vivo
WO2021243683A1 (en) Method for preparing biomedical magnesium alloy wire material
CN106214200B (en) A kind of device suitable for children&#39;s indirect hernia high ligation of hernial sac under laparoscope
CN109811265B (en) Fe-Mn-Cu-C alloy and medical application thereof
WO2021104028A1 (en) Biodegradable ferroalloy, preparation method, and device
CN111803721A (en) Degradable zinc alloy anastomosis instrument and preparation method thereof
CN208851651U (en) With locator markers made of degradable metal
CN107661136A (en) A kind of hysteroscope is closed with degradable Metal Substrate vascular tissue and pressed from both sides
WO2018230415A1 (en) Linear material for medical use
CN111388764A (en) Degradable metal anastomosis nail and preparation method thereof
CN109316624B (en) Integrated degradable cartilage connecting suture with needle

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16853767

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2017544249

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16853767

Country of ref document: EP

Kind code of ref document: A1